NCT06115187

Correlation of Different Ultrasonographic Indices With Clinical Parameters in Carpal Tunnel Syndrome

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey·ClinicalTrials.gov·diagnostic testRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Carpal Tunnel Syndrome
Drug/Device/Intervention
Nerve ultrasound
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Location
Istanbul, Turkey
Timeline & enrollment
Phase
N/A
Start date
Oct 10, 2023
End date
Jun 01, 2024
Enrollment
50 participants
Primary outcome

median nerve ultrasound,median nerve ultrasound,median nerve ultrasound,median nerve ultrasound,median nerve ultrasound,median nerve ultrasound

Summary

The aim of this study is to investigate the relationship between different ultrasonographic
 indices used in patients with carpal tunnel syndrome and clinical parameters.
 
 The main questions it aims to answer are:
 
 - To what extent are the ultrasonographic parameters used in the diagnosis of carpal
 tunnel syndrome related to the patient's clinical complaints?
 
 - To what extent are the different ultrasonographic parameters used in the diagnosis of
 carpal tunnel syndrome correlated with each other?

ICD-10 classifications
Carpal tunnel syndromeTarsal tunnel syndromeArthrosis of first carpometacarpal joint, unspecifiedArthrosis of first carpometacarpal jointOther specified disorders of synovium and tendon
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06115187
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06115187 through Pure Global AI's free database. This phase not specified trial is sponsored by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey and is currently Recruiting. The study focuses on Carpal Tunnel Syndrome. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.